EssilorLuxottica (OTCMKTS:ESLOY) Shares Pass Below Fifty Day Moving Average – Should You Sell?

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOYGet Free Report)’s stock price passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $97.25 and traded as low as $94.56. EssilorLuxottica shares last traded at $95.41, with a volume of 64,889 shares traded.

Wall Street Analyst Weigh In

ESLOY has been the subject of several research reports. The Goldman Sachs Group cut EssilorLuxottica from a “buy” rating to a “hold” rating in a research report on Tuesday, July 14th. Deutsche Bank Aktiengesellschaft started coverage on EssilorLuxottica in a report on Tuesday, May 12th. They issued a “hold” rating on the stock. Finally, Zacks Research cut shares of EssilorLuxottica from a “hold” rating to a “strong sell” rating in a research report on Tuesday, June 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy”.

Get Our Latest Report on ESLOY

EssilorLuxottica Stock Performance

The company has a current ratio of 0.99, a quick ratio of 0.70 and a debt-to-equity ratio of 0.17. The company has a fifty day moving average price of $97.25 and a two-hundred day moving average price of $111.34.

EssilorLuxottica Company Profile

(Get Free Report)

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.

Featured Articles

Receive News & Ratings for EssilorLuxottica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EssilorLuxottica and related companies with MarketBeat.com's FREE daily email newsletter.